Kazia Therapeutics Ltd ADR (KZIA) — Cash Flow Quality Index

Latest as of December 2017: -18.50x

Kazia Therapeutics Ltd ADR (KZIA) has a Cash Flow Quality Index of -18.50x as of December 2017. Operating cash flow of $-7.86 Million is below net income of $424.78K, suggesting accrual-heavy earnings not yet converted to cash. Explore KZIA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-18.50x
Operating CF / Net Income

Operating Cash Flow

$-7.86 Million
USD

Net Income

$424.78K
USD

Data as of

Dec 2017
Most recent filing

Kazia Therapeutics Ltd ADR Cash Flow Quality Index (2000–2012)

Historical Cash Flow Quality Index for Kazia Therapeutics Ltd ADR across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Kazia Therapeutics Ltd ADR cash flow conversion.

Annual Cash Flow Quality Index for Kazia Therapeutics Ltd ADR (2000–2012)

Year-by-year earnings quality comparison for Kazia Therapeutics Ltd ADR.

Year Quality Index Operating CF (USD) Net Income YoY Change
2012 -5.61x $-7.35 Million $1.31 Million ▼ -550.5%
2000 -0.86x $-18.75 Million $21.73 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.